ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
BI drug gets orphan status for MDS
pharmatimes
March 13, 2017Boehringer Ingelheim has bagged US orphan drug designation for its anti-CD33 monoclonal antibody BI 836858 for the treatment of myelodysplastic syndromes (MDS).
Pharma Sources Insight January 2025
